Table 3.
Results of molecular targets prediction
| SN | Ligands | % Probability of predicted targets | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | ||||||||||||||||
| 1 | Dexverapamil | 100 | 100 | 100 | 100 | |||||||||||||||||||||||||||||
| 2 | Emetine | 58 | 40 | |||||||||||||||||||||||||||||||
| 3 | Parthenolide | 63 | 63 | |||||||||||||||||||||||||||||||
| 4 | Dobutamine | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||||||||||||||||||||||
| 5 | Terfenadine | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 52 | |||||||||||||||||||||||||
| 6 | Pimozide | 98 | 98 | 98 | 98 | |||||||||||||||||||||||||||||
| 7 | Mefloquine | 100 | 90 | 98 | ||||||||||||||||||||||||||||||
| 8 | Ellipticine | 100 | ||||||||||||||||||||||||||||||||
| 9 | Trifluoperazine | 35 | 100 | 33 | 100 | 40 | 26 | 100 | ||||||||||||||||||||||||||
Serotonin receptor 2a/2b/2c (HTR2A/HTR2B/HTR2C, P28223/ P41595/P28335). B: HERG (KCNH2, Q12809). C: Adrenergic receptor Alpha-1a/Alpha-2a (ADRA1A /ADRA2A, P35348/P08913). D: Dopamine D3 receptor (DRD3, P35462). E: Small conductance calcium-activated potassium channel protein 1/2/3 (KCNN1/KCNN2/KCNN3, Q92952/Q9H2S1/Q9UGI6). F: Cyclooxygenase-2 (PTGS2, P35354). G: Nitric oxide synthase, inducible (by homology) (NOS2, P35228). H: Adrenergic receptor Alpha-1d/beta-1 (ADRA1D/ADRB1, P25100/P08588). I: Carbonic anhydrase I, II, III, IV, VA, VB, VI, VII, IX, XII, XIII (CA1/CA2/CA3/ CA4/ CA5A/ CA5B/ CA6/ CA7/ CA9, CA12, CA13, P00915/ P00918/ P07451/ P22748/ P35218/ Q9Y2D0/ P23280/ P43166/ Q16790/ O43570/ Q8N1Q1). J: Epidermal growth factor receptor erbB1 (EGFR, P00533). K: Tyrosine-protein kinase FYN/LCK (FYN/LCK, P06241/ P06239). L: Norepinephrine transporter (SLC6A2, P23975). M: C-C chemokine receptor type 5 (CCR5, P51681). N: Muscarinic acetylcholine receptor M1/M2/M4 (CHRM1/CHRM2/CHRM4, P11229/P08172/P08173. O: Ubiquitin carboxylterminal hydrolase 1 (USP1, O94782). P: Glycine receptor subunit alpha-1 (GLRA1, P23415). Q: Adenosine receptor A1,A2a, A2b, A3 (ADORA1, ADORA2a, ADORA2b ADORA3, P30542/P29274/ P29275/P0DMS8). R: DNA topoisomerase II alpha (TOP2A, P11388). S: Anti-estrogen binding site (AEBS) (EBP, Q15125)